Dentsply Sirona

Bronstein, Gewirtz & Grossman, LLC Notifies Dentsply Sirona, Inc. (XRAY) Investors With Losses Exceeding $1 Million of Class Action and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, June 14, 2022
Court, Lists of schools in England, GLOBE, Company, Review, GAAP, LLC, Person, NASDAQ, Complaint, Private investigator, Dentsply Sirona

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws.

Key Points: 
  • This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws.
  • As a result of these misrepresentations, Dentsply stock traded at artificially inflated prices throughout the Class Period.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484.
  • Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CareDx, Spero, LMP Automotive, and Dentsply Sirona and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, June 14, 2022
New Drug Application, Mission statement, Company, Workforce, Sale, Review, COVID-19, Tebipenem, Superior, California superior courts, HBR, Marketing, Infection, Food, Income, Degenerative disease, Urinary tract infection, Spero, Population, LMP, NDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Relevant, Kidney, Audit committee, Class Action, Government, Physician, Justice, Patient, XRAY, Plaque, SEC, Complaint, CDNA, Anesthetic, Annual report, Medicare, Complicated, News, Treatment, Dentsply Sirona, FDA, Growth, ASP, GLOBE, Defendant, Risk, NASDAQ, Board, Lists of schools in England, Documentation, Pharmaceutical industry, Animal, Renewable energy, Audit, Medical device, Property management, Pyelonephritis, P.C

Throughout the Class Period, CareDx reported growing revenue and strong demand in the Companys testing services segment.

Key Points: 
  • Throughout the Class Period, CareDx reported growing revenue and strong demand in the Companys testing services segment.
  • For more information on the LMP class action go to: https://bespc.com/cases/LMPX
    Dentsply is a dental equipment manufacturer with offices across the United States.
  • For more information on the Dentsply Sirona class action go to: https://bespc.com/cases/XRAY
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DENTSPLY SIRONA Inc. - XRAY

Retrieved on: 
Tuesday, June 14, 2022
Company, GLOBE, News, LLP, Dentsply Sirona, NASDAQ, Pomerantz, Private investigator

NEW YORK, June 13, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Dentsply Sirona Inc. (Dentsply Sirona or the Company) (NASDAQ: XRAY).

Key Points: 
  • NEW YORK, June 13, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Dentsply Sirona Inc. (Dentsply Sirona or the Company) (NASDAQ: XRAY).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether Dentsply Sirona and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Iovance Biotherapeutics Appoints Wendy L. Dixon, Ph.D., to Board of Directors

Retrieved on: 
Monday, June 13, 2022
Diamond, Board, Life, Marketing, PBL, University, Popular Executive Committee of Valencia, PSLRA, GlaxoSmithKline, Natural science, Food, Merck & Co., Orexigen Therapeutics, Annual report, Perception, Private Securities Litigation Reform Act, Forward-looking statement, Security (finance), Executive Committee, U.S. Securities and Exchange Commission, Organization, Cervical cancer, Risk, FDA, Therapy, BMS, Doctor of Philosophy, Patient, Dentsply Sirona, GLOBE, Bristol Myers Squibb, TIL, COVID-19, Lists of companies, Food and Drug Administration, NASDAQ, SAN, BLA, Merck, Cancer, Safety, Global marketing, Pharmaceutical industry, Medical imaging, Janssen Biotech, Iovance Biotherapeutics, Iovance Biotherapeutics, Biochemistry, West Pharmaceutical Services explosion

Phil., Chairman of the Board of Directors of Iovance, stated, Wendy has a successful track record in commercial leadership and new product launches, as well as a strong reputation for strategic thinking and executional focus.

Key Points: 
  • Phil., Chairman of the Board of Directors of Iovance, stated, Wendy has a successful track record in commercial leadership and new product launches, as well as a strong reputation for strategic thinking and executional focus.
  • Iovance is fortunate to have Wendy join our board as we prepare to submit our first BLA and transition into a fully-integrated commercial organization with a rich development pipeline.
  • I am thrilled to join the Iovance board during this important journey toward commercialization and pipeline innovation, said Dr. Dixon.
  • Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer.

XRAY INVESTORS: August 1, 2022 Filing Deadline in Securities Class Action – Contact Lieff Cabraser

Retrieved on: 
Thursday, June 9, 2022
Legal, Professional Services, Benchmark, Committee on Finance, Company, Audit committee, Anesthetic, Court, The National Law Journal, News, Security (finance), Degenerative disease, XRAY, Plaque, Board, Lists of schools in England, Audit, LLP, Dentsply Sirona, U.S. Securities and Exchange Commission, Tobacco

If you purchased Dentsply common stock during the Class Period, you may move the Court for appointment as lead plaintiff by no later than August 1, 2022.

Key Points: 
  • If you purchased Dentsply common stock during the Class Period, you may move the Court for appointment as lead plaintiff by no later than August 1, 2022.
  • A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.
  • You may retain Lieff Cabraser, or other attorneys, as your counsel in the action.
  • The National Law Journal has recognized Lieff Cabraser as one of the nations top plaintiffs law firms for fourteen years.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against LMP, Dentsply Sirona, IonQ, and Energy Transfer and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, June 9, 2022
Transfer, HDD, Mission statement, Company, Transport, Complaint, Natural gas, Technology, Review, NYSE, Master limited partnership, Form 10-Q, IonQ, Research report, Income, Partnership, Energy Transfer Partners, Degenerative disease, Quantum, LMP, Relevant, Tuscarawas, Audit committee, FERC, XRAY, Plaque, SEC, Tuscarawas River, Energy, NGL, Enforcement, Anesthetic, Annual report, News, Federal Energy Regulatory Commission, Dentsply Sirona, GLOBE, Defendant, NASDAQ, Board, Lists of schools in England, P.C, Documentation, Medical device, Cryptocurrency, Renewable energy, Audit, Property management, Risk management

On this news, the Companys stock price fell $0.19, or 3.8%, to close at $4.81 per share on April 1, 2022.

Key Points: 
  • On this news, the Companys stock price fell $0.19, or 3.8%, to close at $4.81 per share on April 1, 2022.
  • The Company also disclosed that these errors may impact certain previously disclosed material weaknesses in the registrants controls over financial reporting.
  • For more information on the IonQ class action go to: https://bespc.com/cases/IONQ
    Energy Transfer is a Delaware company headquartered in Dallas, Texas.
  • For more information on the Energy Transfer class action go to: https://bespc.com/cases/ET
    About Bragar Eagel & Squire, P.C.

XRAY INVESTOR NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Dentsply Sirona Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – XRAY

Retrieved on: 
Wednesday, June 8, 2022
Titan, Facebook, THE, LinkedIn, Court, Class, GLOBE, WHY, XRAY, GAAP, NASDAQ, Advertising, SEC, Twitter, Lists of schools in England, Dentsply Sirona, I-Space (Chinese company), TO, Tobacco, Insurance

WHAT TO DO NEXT: To join the Dentsply class action, go to https://rosenlegal.com/submit-form/?case_id=6111 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Dentsply class action, go to https://rosenlegal.com/submit-form/?case_id=6111 or call Phillip Kim, Esq.
  • toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Bronstein, Gewirtz & Grossman, LLC Notifies Dentsply Sirona, Inc. (XRAY) Investors of Class Action and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, June 8, 2022
Legal, Professional Services, Court, Lists of schools in England, Company, Review, XRAY, GAAP, LLC, Person, NASDAQ, Complaint, Private investigator, Dentsply Sirona

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws.

Key Points: 
  • This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws.
  • The Complaint alleges that throughout the Class Period, Defendants touted its "go-tomarket strategy" and "more sophisticated and strategic incentive plans" as drivers of the Company's success.
  • As a result of these misrepresentations, Dentsply stock traded at artificially inflated prices throughout the Class Period.
  • Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits.

XRAY INVESTORS: August 1, 2022 Filing Deadline in Securities Class Action – Contact Lieff Cabraser

Retrieved on: 
Wednesday, June 8, 2022
Legal, Professional Services, Benchmark, Committee on Finance, Company, Audit committee, Anesthetic, Court, The National Law Journal, News, Security (finance), Degenerative disease, XRAY, Plaque, Board, Lists of schools in England, Audit, LLP, Dentsply Sirona, U.S. Securities and Exchange Commission, Tobacco

If you purchased Dentsply common stock during the Class Period, you may move the Court for appointment as lead plaintiff by no later than August 1, 2022.

Key Points: 
  • If you purchased Dentsply common stock during the Class Period, you may move the Court for appointment as lead plaintiff by no later than August 1, 2022.
  • A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.
  • You may retain Lieff Cabraser, or other attorneys, as your counsel in the action.
  • The National Law Journal has recognized Lieff Cabraser as one of the nations top plaintiffs law firms for fourteen years.

EQUITY ALERT: ROSEN, A TOP RANKED FIRM, Encourages Dentsply Sirona Inc. Investors With Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action – XRAY

Retrieved on: 
Tuesday, June 7, 2022
Legal, Professional Services, Titan, Facebook, THE, LinkedIn, Court, Class, WHY, XRAY, GAAP, NASDAQ, Advertising, SEC, Twitter, Lists of schools in England, Dentsply Sirona, I-Space (Chinese company), TO, Tobacco, Insurance

WHAT TO DO NEXT: To join the Dentsply class action, go to https://rosenlegal.com/submit-form/?case_id=6111 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Dentsply class action, go to https://rosenlegal.com/submit-form/?case_id=6111 or call Phillip Kim, Esq.
  • toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.